해시 게임 바카라 and China’s in vitro diagnostics company KHB sign MOU on co-development of lung cancer and depression diagnostic tests

[by Kang, In Hyo] BeyondDx, a company specializing in the development of multi-integrated analytical solutions, announced on August 21 that it has entered into a Memorandum of Understanding (MOU) with China’s Shanghai Kehua Bio-Engineering (KHB) for the co-development and global commercialization of its ForeCheck LC (early lung cancer diagnosis) and MDD (major depressive disorder diagnosis) technologies.

Established in 1981, KHB is a leading Chinese in vitro diagnostic (IVD) 해시 게임 바카라 with a comprehensive product portfolio encompassing immunoassays, molecular diagnostics, and clinical chemistry. The 해시 게임 바카라 also operates an extensive sales and marketing network across China, Asia, Europe, Latin America, and other global markets. Its production facilities and research centers hold international standard certifications, ensuring a reliable supply chain and robust global distribution capabilities.

BeyondDx has been developing high-precision, blood-based early diagnosis technologies built around its artificial intelligence (AI) and machine learning (ML)-driven multi-biomarker analysis platform, ‘iDXGate SN.’ According to the company, ForeCheck LC serves as an early lung cancer screening test employing liquid biopsy technology, while its MDD diagnostic platform integrates blood biomarkers with AI algorithms to increase the accuracy of differential diagnosis for mental health disorders, including depression and bipolar disorder.

Through this MOU, the two companies plan to integrate KHB's global sales and marketing expertise with 해시 게임 바카라's innovative diagnostic technologies to co-develop next-generation diagnostic solutions that deliver clinical value and commercial competitiveness in the areas of lung cancer and mental health disorders. The partnership aims to accelerate commercialization and drive market expansion in China as well as in the global market.

"By using KHB's global distribution network and market reach, our AI and ML-based precision diagnostic technologies will be delivered to patients worldwide more rapidly and extensively. This collaboration represents an opportunity for both companies to further strengthen their global competitiveness," said Lee Gwang-hyouk, vice president of BeyondDx.